KFDA to ameliorate biosimilar related rules

The Korea Food and Drug Administration has recently unveiled its plan to effectively implement the recently updated biosimilar regulations as part of efforts to promote local biosimilar business.

The drug agency said on July 15 that some of the rules concerning the license of biological products, including biosimilars, have been eased for ameliorating unnecessary procedures in the screening ...